A Safety and Efficacy Study of PDFE-2304 Topical Solution for the Treatment of Androgenic Alopecia.

NCT07011485 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

Alopecia, Androgenetic
Baldness
Androgenetic Alopecia (AGA)

Interventions

DRUG: Minoxidil 5% Topical Solution
DRUG: PDFE-2304 Topical Solution

Sponsor

PDFE Pharma Innovations FZCO